DeBattista C, Mueller K
Department of Psychiatry and Behavioral Sciences, Stanford (Calif) University School of Medicine 94305, USA.
Headache. 1995 Sep;35(8):502-3. doi: 10.1111/j.1526-4610.1995.hed3508502.x.
Very little has been written about headaches following electroconvulsive therapy (ECT) but the incidence has been estimated at 26%. Patients with a history of migraine occasionally have similar headaches precipitated by ECT. In addition, some patients may have headaches that persist for months after a series of ECT treatments, while some patients who have a preexisting headache problem report improvement with ECT. Serotonergic mechanisms have been proposed both for the efficacy of ECT and its tendency to produce headaches in susceptible patients. There have been no studies on the prophylaxis or treatment of post-ECT headache. While various strategies have been suggested for these headaches, even case reports documenting the efficacy of these strategies are lacking. We, therefore, report a case of severe, refractory, post-ECT headaches which responded to prophylactic treatment with sumatriptan.
关于电休克治疗(ECT)后头痛的文献报道极少,但据估计其发生率为26%。有偏头痛病史的患者偶尔会因ECT诱发类似的头痛。此外,一些患者在接受一系列ECT治疗后可能会出现持续数月的头痛,而一些原本就有头痛问题的患者报告称ECT后症状有所改善。血清素能机制被认为与ECT的疗效及其在易感患者中引发头痛的倾向有关。目前尚无关于ECT后头痛预防或治疗的研究。虽然针对这些头痛提出了各种策略,但甚至缺乏记录这些策略有效性的病例报告。因此,我们报告一例严重、难治性的ECT后头痛病例,该病例对舒马曲坦预防性治疗有反应。